Production of monoclonal antibodies using hybridoma technology took advantage of the fact that:
a) The ability to live forever in tissue culture is a characteristic of antigen-activated B cells
b) The ability to live forever in tissue culture is a characteristic of myeloma cells
c) All options are correct
d) Myeloma cells secrete antibodies of known, desired specificity